News
CV Sciences is trading at just a 4.2x EV/Sales multiple, which we think is low given that the company is profitable and growing revenues in excess of 30% on a YoY basis.
Earnings Call Insights: CV Sciences (CVSI) Q4 2024 Management View CEO Joseph Dowling highlighted the company’s focus on scaling its business, achieving cost efficiencies, and transitioning to a ...
CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Tuesday its financial results for the second quarter that ended June 30, 2024, revealing a flat revenue year-over-year ...
I can see why a risk-loving investor might take a gamble on CV Sciences (OTCMKTS: CVSI). Those who have already taken the plunge have done quite well. CV Sciences, somewhat incredibly, has risen ...
--CV Sciences, Inc., a preeminent leader in hemp derived cannabidiol products, today announced the launch of ProCBD™, a full product line of clinical strength CBD products available exclusively ...
CBD growth is expected to be exponential over the course of the next several years; CV Sciences supplies to White Label products and can capitalize on this growth potential; Declining revenues ...
CV Sciences, Inc. (OTCQB: CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, ...
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent l ...
CV Sciences, Inc. (OTCQB: CVSI) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of $4.1 million for the first quarter of 2023 compared to $4.4 ...
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp ...
Clinical Strength ProCBD™ is Supported by Clinical Research and Available Exclusively Through Health Practitioners CV Sciences, Inc. Announces Launch of ProCBD™ Product Line Clinical Strength ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results